AbelZeta Pharma, AstraZeneca to co-develop a novel GPC3 armored CAR-T therapy in China
C-CAR031 is based on a novel GPC3-targeting CAR-T (AZD5851) designed by AstraZeneca using their transforming growth factor-beta receptor II
C-CAR031 is based on a novel GPC3-targeting CAR-T (AZD5851) designed by AstraZeneca using their transforming growth factor-beta receptor II
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
The esteemed duo perfectly embody the brand's core values of family, love, and the special bond we share with our pets
High-quality baobab oil sourced in collaboration with UNCCD and the Great Green Wall Initiative
The new ECO grade is made using renewable feedstock
This cell will serve as an extension of the Tele Mental Health Assistance and Networking Across States initiative of the Ministry of Health and Family welfare
Global Ayurveda Festival organising in Thiruvananthapuram from 1st to 5th December
South Asia’s largest Trade Fair for pharma brought together over 50,000 visitors from across the globe, more than 1,500 exhibitors showcasing 10,000+ products and representation from over 80 countries
Almost 300 million people globally have chronic hepatitis B
Subscribe To Our Newsletter & Stay Updated